Stress and Inflammatory Disease: Widening Roles for Serotonin and Substance P

References

• Abbas A. K., Murphy K. M., Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 383–787
   PubMedGoogle Scholar
• Aguiar M. S., Brandao M. L. Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test. Physiol. Behav. 1996; 60: 1183–1186
   PubMedGoogle Scholar
• Alstergren P., Kopp S., Theodorsson E. Synovial fluid sampling from the temporomandibular joint: sample quality criteria and levels of interleukin-1 beta and serotonin. Acta Odontol. Scand. 1999; 57: 16–22
   PubMed Web of Science ®Google Scholar
• Arzt E., Costas M., Finkielman S., Nahmod V. E. Serotonin inhibition of tumor necrosis factor-alpha synthesis by human monocytes. Life Sci. 1991; 48: 2557–2562
   PubMed Web of Science ®Google Scholar
• Bannon M. J., Elliott P. J., Alpert J. E., Goedert M., Iversen S. D., Iversen L. L. Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurones. Nature 1983; 306: 791–792
   PubMedGoogle Scholar
• Barton C. L., Jay M. T., Meurer L., Hudson P. H. GR205171, a selective NK1 receptor antagonist attenuates stess-induced increase of dopamine metabolism in rat medial prefrontal cortex. Br. J. Pharmacol. 1999; 126: 284P
   Google Scholar
• Basbaum A. I. Spinal mechanisms of acute and persistent pain. Reg. Anesth. Pain Med. 1999; 24: 59–67
   PubMed Web of Science ®Google Scholar
• Bertini R., Bianchi M., Ghezzi P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J. Exp. Med. 1988; 167: 1708–1712
   PubMedGoogle Scholar
• Bittencourt J. C., Benoit R., Sawchenko P. E. Distribution and origins of substance P-immunoreactive projections to the paraventricular and supraoptic nuclei: partial overlap with ascending catecholaminergic projections. J. Chem. Neuroanat. 1991; 4: 63–78
   PubMed Web of Science ®Google Scholar
• Chaouloff F. Serotonin, stress and corticoids. J. Psychopharmacol. 2000; 14: 139–151
   PubMedGoogle Scholar
• Chowdrey H. S., Jessop D. S., Lightman S. L. Substance P stimulates arginine vasopressin and inhibits adrenocorticotropin release in vivo in the rat. Neuroendocrinology 1990; 52: 90–93
   PubMedGoogle Scholar
• Chowdrey H. S., Jessop D. S., Patel H., Lightman S. L. Altered adrenocorticotropin, corticosterone and oxytocin responses to stress during chronic salt load. Neuroendocrinology 1991; 54: 635–638
   PubMed Web of Science ®Google Scholar
• Chowdrey H. S., Larsen P. J., Harbuz M. S., Lightman S. L., Jessop D. S. Endogenous substance P inhibits the expression of corticotropin-releasing hormone during a chronic inflammatory stress. Life Sci. 1995; 57: 2021–2029
   PubMed Web of Science ®Google Scholar
• Conde G. L., Renshaw D., Lightman S. L., Harbuz M. S. Serotonin depletion does not alter lipopolysaccharide-induced activation of the rat paraventricular nucleus. J. Endocrinol. 1998; 156: 245–251
   PubMed Web of Science ®Google Scholar
• Connor T. J., Kelly J. P., Leonard B. E. An assessment of the acute effects of the serotonin releasers mefhylenedi-oxymethamphetamine, methyl-enedioxyamphetamine and fenfluramine on immunity in rats. Immunopharmacology 2000; 46: 223–235
   PubMedGoogle Scholar
• Culman J., Itoi K., Unger T. Hypothalamic tachykinins: mediators of stress responses?. Ann. N.Y. Acad. Sci. 1995; 771: 204–218
   PubMedGoogle Scholar
• Culman J., Klee S., Ohlendorf C., Unger T. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress. J. Pharmacol. Exp. Ther. 1997; 280: 238–246
   PubMedGoogle Scholar
• Darlington D. N., Neves R. B., Ha T., Chew G., Dallman M. F. Fed, but not fasted, adrenalectomised rats survive the stress of hemorrhage and hypovolemia. Endocrinology 1990; 127: 759–765
   PubMedGoogle Scholar
• De Felipe C., Herrero J. F., O'Brien J. A., Palmer J. A., Doyle C. A., Smith A. J., Laird J. M., Belmonte C., Cervero F., Hunt S. P. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 1998; 392: 394–397
   PubMed Web of Science ®Google Scholar
• De Kloet E. R., Vreugdenhil E., Oitzl M. S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 1998; 19: 269–301
   PubMed Web of Science ®Google Scholar
• Dinan T. G. Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function. Life Sci. 1996; 58: 1683–1694
   PubMed Web of Science ®Google Scholar
• Dunn A. J. Changes in plasma and brain tryptophan and brain serotonin and 5–hydroxyindoleacetic acid after foot-shock stress. Life Sci. 1988; 42: 1847–1853
   PubMed Web of Science ®Google Scholar
• Elliott P. J. Place aversion induced by the substance P analogue, dimethyl-C7, is not state dependent: implication of substance P in aversion. Exp. Brain Res. 1988; 73: 354–356
   PubMedGoogle Scholar
• Faria M., Navarra P., Tsagarakis S., Besser G. M., Grossman A. B. Inhibition of CRH-41 release by substance P, but not substance K, from the rat hypothalamus in vitro. Brain Res. 1991; 538: 76–78
   PubMed Web of Science ®Google Scholar
• Feldman S., Conforti N., Melamed E. Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretion. Brain Res. Bull. 1987; 18: 165–168
   PubMedGoogle Scholar
• Feldman S., Weidenfeld J., Conforti N., Saphier D. Differential recovery of adrenocortical responses to neural stimuli following administration of 5,7-dihydroxytryptamine into the hypothalamus. Exp. Brain Res. 1991; 85: 144–148
   PubMedGoogle Scholar
• Feldmann M., Bondeson J., Brennan F. M., Foxwell B. M., Maini R. N. The rationale for the current boom in anti-TNFalpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards?. Ann. Rheum. Dis. 1999; 58(Suppl 1)127–131
   Google Scholar
• Garzon J., Lerida M., Sanchez-Blazquez P. Effect of intrathecal injection of pertussis toxin on substance P, norepinephrine and serotonin contents in various neural structures of arthritic rats. Life Sci. 1990; 47: 1915–1923
   PubMedGoogle Scholar
• Givalois L., Becq H., Siaud P., Ixart G., Assenmacher I., Barbanel G. Serotoninergic and suprachiasmatic nucleus involvement in the corticotropic response to systemic endotoxin challenge in rats. J. Neuroendocrinal. 1999; 11: 629–636
   PubMedGoogle Scholar
• Guyenet P. G., Aghajanian G. K. Excitation of neurons in the nucleus locus coeruleus by substance P and related peptides. Brain Res. 1977; 136: 178–184
   PubMedGoogle Scholar
• Hahn M. K., Bannon M. J. Tachykinin NK1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus. Eur. J. Pharmacol. 1998; 348: 155–160
   PubMedGoogle Scholar
• Hahn M. K., Bannon M. J. Stress-induced C-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activation. Neuroscience 1999; 94: 1183–1188
   PubMedGoogle Scholar
• Harbuz M. S. Chronic inflammatory stress. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 1999; 13: 555–565
   PubMedGoogle Scholar
• Harbuz M. S., Rees R. G., Eckland D., Jessop D. S., Brewerton D., Lightman S. L. Paradoxical responses of hypothalamic CRF mRNA and CRF-41 peptide and adenohypophyseal POMC mRNA during chronic inflammatory stress. Endocrinology 1992; 130: 1394–1400
   PubMed Web of Science ®Google Scholar
• Harbuz M. S., Rees R. G., Lightman S. L. Hypothalamo-pituitary responses to acute stress and changes in circulating glucocorticoids during chronic adjuvant-induced arthritis in the rat. Am. J. Physiol. 1993a; 264: R179–R185
   Google Scholar
• Harbuz M. S., Chalmers J., De Souza L., Lightman S. L. Stress-induced activation of CRF and c-fos mRNAs in the paraventricular nucleus are not affected by serotonin depletion. Brain Res. 1993b; 609: 167–173
   PubMedGoogle Scholar
• Harbuz M. S., Perveen-Gill Z., Lalies M. D., Jessop D. S., Lightman S. L., Chowdrey H. S. The role of endogenous serotonin in adjuvant-induced arthritis. Br. J. Rheumatol. 1996; 35: 112–116
   PubMedGoogle Scholar
• Harbuz M. S., Conde G. L., Marti O., Lightman S. L., Jessop D. S. The hypothalamic-pituitary-adrenal axis in autoimmunity. Ann. N. Y. Acad. Sci. 1997; 823: 214–224
   PubMedGoogle Scholar
• Harbuz M. S., Marti O., Lightman S. L., Jessop D. S. Alteration of central serotonin modifies onset and severity of adjuvant-induced arthritis in the rat. Br. J. Rheumatol. 1998; 37: 1077–1083
   PubMedGoogle Scholar
• Harbuz M. S., Windle R. J., Jessop D. S., Renshaw D., Ingram C. D., Lightman S. L. Differential effects of psychological and immunological challenge on the hypothalamo-pituitary-adrenal axis function in adjuvant-induced arthritis. Ann. N. Y. Acad. Sci. 1999a; 876: 43–52
   PubMed Web of Science ®Google Scholar
• Harbuz M. S., Rooney C., Jones M., Ingram C. D. Hypothalamo-pituitary-adrenal axis responses to lipopolysaccharide in male and female rats with adjuvant-induced arthritis. Brain Behav. Immun. 1999b; 13: 335–347
   PubMedGoogle Scholar
• Hayley S., Brebner K., Lacosta S., Merali Z., Anisman H. Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations. J. Neurosci. 1999; 19: 5654–5665
   PubMed Web of Science ®Google Scholar
• Hill R. NK1 (substance P) receptor antagonists - why are they not analgesic in humans?. Trends Pharmacol. Sci. 2000; 21: 244–246
   PubMed Web of Science ®Google Scholar
• Holmes M. C., French K. L., Seckl J. R. Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress. Mol. Brain Res. 1995; 28: 186–192
   PubMedGoogle Scholar
• Hood S. D., Argyropoulos S. V., Nutt D. J. Arthritis and serotonergic antidepressants. Neuroimmunomodulation 2000; 7: 214
   Google Scholar
• Jackson J. C., Walker R. F., Brooks W. H., Roszman T. L. Specific uptake of serotonin by murine macrophages. Life Sci. 1988; 42: 1641–1650
   PubMed Web of Science ®Google Scholar
• Jessop D. S. Stimulatory and inhibitory regulators of the hypothalamo-pituitary-adrenocortical axis. Baillières Best Pract. Res. Clin. Endocrinol. Metab. 1999a; 13: 491–501
   PubMed Web of Science ®Google Scholar
• Jessop D. S. Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. J. Endocrinol. 1999b; 160: 169–180
   PubMed Web of Science ®Google Scholar
• Jessop D. S., Renshaw D., Larsen P. J., Chowdrey H. S., Harbuz M. S. Substance P is involved in terminating the hypothalamo-pituitary-adrenal axis response to acute stress through centrally located neurokinin-1 receptors. Stress 2000; 3: 209–220
   PubMedGoogle Scholar
• Johnson W. J., Muirhead K. A., Meunier P. C., Votta B. J., Schmitt T. C., DiMartino M. J., Hanna N. Macrophage activation in rat models of inflammation and arthritis. Systemic activation precedes arthritis induction and progression. Arthritis Rheum. 1986; 29: 1122–1130
   PubMedGoogle Scholar
• Kinne R. W., Schmidt-Weber C. B., Hoppe R., Buchner E., Palombo-Kinne E., Nurnberg E., Emmrich F. Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate-containing liposomes. Arthritis Rheum. 1995; 38: 1777–1790
   PubMed Web of Science ®Google Scholar
• Kopp S. The influence of neuropeptides, serotonin, and interleukin 1beta on temporomandibular joint pain and inflammation. J. Oral Maxillofac. Surg. 1998; 56: 189–191
   PubMed Web of Science ®Google Scholar
• Kramer M. S., Cutler N., Feighner J., Shrivastava R., Carman J., Sramek J., Reines S., Liu G., Snavely D., Wyatt-Knowles E., et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 1998; 281: 1640–1645
   PubMed Web of Science ®Google Scholar
• Krase W., Koch M., Schnitzler H. U. Substance P is involved in the sensitization of the acoustic startle response by footshocks in rats. Behav. Brain Res. 1994; 63: 81–88
   PubMedGoogle Scholar
• Krowicki Z. K., Hornby P. J. Substance P in the dorsal motor nucleus of the vagus evokes gastric motor inhibition via neurokinin 1 receptor in rat. J. Pharmacol. Exp. Ther. 2000; 293: 214–221
   PubMedGoogle Scholar
• Ku Y. H., Tan L., Li L. S., Ding X. Role of corticotropin-releasing factor and substance P in pressor responses of nuclei controlling emotion and stress. Peptides 1998; 19: 677–682
   PubMedGoogle Scholar
• Kut J. L., Young M. R., Crayton J. W., Wright M. A., Young M. E. Regulation of murine T-lymphocyte function by spleen cell-derived and exogenous serotonin. Immunopharmacol. Immunotoxicol. 1992; 14: 783–796
   PubMed Web of Science ®Google Scholar
• Larsen P. J. Distribution of substance P-immunoreactive elements in the preoptic area and the hypothalamus of the rat. J. Comp. Neurol. 1992; 316: 287–313
   PubMedGoogle Scholar
• Larsen P. J., Jessop D., Patel H., Lightman S. L., Chowdrey H. S. Substance P inhibits the release of anterior pituitary adrenocorticotrophin via a central mechanism involving corticotrophin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus. J. Neuroendocrinal. 1993; 5: 5–99
   Google Scholar
• Levine J. D., Fields H. L., Basbaum A. I. Peptides and the primary afferent nociceptor. J. Neurosci. 1993; 13: 2273–2286
   PubMed Web of Science ®Google Scholar
• Linthorst A. C.E., Flachskamm C., Holsboer F., Reul J. M.H.M. Local administration of recombinant human interleukin 1-beta in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity, and body temperature. Endocrinology 1994; 135: 520–532
   PubMedGoogle Scholar
• Linthorst A. C.E., Flachskamm C., Holsboer F., Reul J. M.H.M. Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin: involvement of the cyclo-oxygenase pathway. Neuroscience 1996; 72: 989–997
   PubMed Web of Science ®Google Scholar
• Linthorst A. C.E., Flachskamm C., Muller-Preuss P., Holsboer F., Reul J. M.H.M. Effect of bacterial endotoxin and interleukin 1-beta on hippocampal serotonergic neurotransmission, behavioural activity and free corticosterone levels: an in vivo microdialysis study. J. Neurosci. 1995; 15: 2920–2934
   PubMed Web of Science ®Google Scholar
• Liposits Z., Phelix C., Paull W. K. Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immuno-cytochemical study. Histochemistry 1987; 86: 541–549
   PubMedGoogle Scholar
• Lundberg J. M., Hökfelt T., Kewenter J., Pettersson G., Ahlman H., Edin R., Dahlstrom A., Nilsson G., Terenius L., Uvnas-Wallensten K., Said S. Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve. Gastroenterology 1979; 77: 468–471
   PubMed Web of Science ®Google Scholar
• Maier S. F., Goehler L. E., Fleshner M., Watkins L. R. The role of the vagus nerve in cytokine-to-brain communication. Ann. N.Y. Acad. Sci. 1998; 840: 289–300
   PubMed Web of Science ®Google Scholar
• Mansikka H., Sheth R. N., DeVries C., Lee H., Winchurch R., Raja S. N. Nerve injury-induced mechanical but not thermal hyperalgesia is attenuated in neurokinin-1 receptor knockout mice. Exp. Neurol. 2000; 162: 343–349
   PubMed Web of Science ®Google Scholar
• Mansikka H., Shiotani M., Winchurch R., Raja S. N. Neurokinin-1 receptors are involved in behavioral responses to high-intensity heat stimuli and capsaicin-induced hyperalgesia in mice. Anesthesiology 1999; 90: 1643–1649
   PubMed Web of Science ®Google Scholar
• Mantyh P. W., Gates T., Mantyh C. R., Maggio J. E. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J. Neurosci. 1989; 9: 258–279
   PubMedGoogle Scholar
• Marlier L., Poulat P., Rajaofetra N., Privat A. Modifications of serotonin-, substance P- and calcitonin gene-related peptide-like immunoreactivities in the dorsal horn of the spinal cord of arthritic rats: a quantitative immunocytochemical study. Exp. Br. Res. 1991; 85: 482–490
   PubMedGoogle Scholar
• Mikkelsen J. D., Larsen P. J., Moller M., Vilhardt H., Saermark T. Substance P in the median eminence and pituitary of the rat: demonstration of immunoreactive fibers and specific binding sites. Neuroendocrinol 1989; 50: 50–100
   Google Scholar
• Miossec P., van den Berg W. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum. 1997; 40: 2105–2115
   PubMed Web of Science ®Google Scholar
• MohanKumar S. M., MohanKumar P. S., Quadri S. K. Lipopolysaccharide-induced changes in monoamines in specific areas of the brain: blockade by interleukin-1 receptor antagonist. Brain Res. 1999; 824: 232–237
   PubMedGoogle Scholar
• Mossner R., Heils A., Stober G., Okladnova O., Daniel S., Lesch K. P. Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by inter-leukin-6. Neurochem. Int. 1998; 33: 251–254
   PubMed Web of Science ®Google Scholar
• Mossner R., Lesch K.-L. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav. Immun. 1998; 12: 249–271
   PubMed Web of Science ®Google Scholar
• Munck A., Naray-Fejes-Tofh A. Glucocorticoids and stress: permissive and suppressive actions. Ann. N.Y. Acad. Sci. 1994; 746: 115–130
   PubMed Web of Science ®Google Scholar
• Pertsch M., Krause E., Hirschelmann R. A comparison of serotonin (5-HT) blood levels and activity of 5-HT2 antagonists in adjuvant arthritic Lewis and Wistar rats. Agents & Actions 1993; 38: C98–101, Spev no.
   Google Scholar
• Quartara L., Maggi C. A. The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation. Neuropeptides 1997; 31: 537–563
   PubMed Web of Science ®Google Scholar
• Quartara L., Maggi C. A. The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles. Neuropeptides 1998; 32: 1–49
   PubMed Web of Science ®Google Scholar
• Ranee N, Bruce E. TR. Neurokinin B gene expression is increased in the arcuate nucleus of ovariectomized rats. Neuroendocrinology 1994; 60: 337–345
   PubMedGoogle Scholar
• Rees L. H., Cook D. M., Kendall J. W., Allen C. F., Kramer R. M., Ratcliffe J. G., Knight R. A. A radioimmunoassay for rat plasma ACTH. Endocrinology 1971; 89: 254–261
   PubMed Web of Science ®Google Scholar
• Roszman T. L., Brooks W. H. Neural modulation of immune function. J. Neuroimmunol. 1985; 10: 59–69
   PubMed Web of Science ®Google Scholar
• Rupniak N. M., Carlson E. C., Harrison T., Oates B., Seward E., Owen S., de Felipe C., Hunt S., Wheeldon A. Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice. Neuropharmacology 2000; 39: 1413–1421
   PubMed Web of Science ®Google Scholar
• Rupniak N. M., Kramer M. S. Discovery of the antidepressant and antiemetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol. Sci. 1999; 20: 485–490
   PubMed Web of Science ®Google Scholar
• Sakuma M., Yoshioka K., Suzuki H., Yanagisawa M., Onishi Y., Kobayashi N., Otsuka M. Substance P-evoked release of GABA from isolated spinal cord of the newborn rat. Neuroscience 1991; 45: 323–330
   PubMedGoogle Scholar
• Saphier D., Welch J. E., Farrar G. E., Nguyen N. Q., Aguado F., Thaller T. R., Knight D. S. Interactions between serotonin, thyrotropin-releasing hormone, and substance P in the CNS regulation of adrenocortical secretion. Psychoneuroendocrinology 1994; 19: 779–797
   PubMedGoogle Scholar
• Shaikh M. B., Steinberg A., Siegel A. Evidence that substance P is utilized in medial amygdaloid facilitation of defensive rage behavior in the cat. Brain Res. 1993; 625: 283–294
   PubMedGoogle Scholar
• Shintani F., Nakaki T., Kanba S., Sato K., Yagi G., Shiozawa M., Aiso S., Kato R., Asai M. Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat. J. Neurosci. 1995; 15: 1961–1970
   PubMed Web of Science ®Google Scholar
• Steiner G., Tohidast-Akrad M., Witzmann G., Vesely M., Studnicka-Benke A., Gal A., Kunaver M., Zenz P., Smolen I. S. Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology 1999; 38: 202–213
   PubMed Web of Science ®Google Scholar
• Sufka K. J., Schomburg F. M., Giordano J. Receptor mediation of 5-HTinduced inflammation and nociception in rats. Pharmacol. Biochem. Behav. 1991; 41: 53–56
   Google Scholar
• Unger T., Becker H., Petty M., Demmert G., Schneider B., Ganten D., Lang R. E. Differential effects of central angiotensin II and substance P on sympathetic nerve activity in conscious rats. Implications for cardiovascular adaptation to behavioral responses. Circ. Res. 1985; 56: 563–575
   PubMed Web of Science ®Google Scholar
• Vedhara K., Cox N. K., Wilcock G. K., Perks P., Hunt M., Anderson S., Lightman S. L., Shanks N. M. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 1999; 353: 627–631
   PubMed Web of Science ®Google Scholar
• Weil-Fugazza I., Godefroy F., Besson J. M. Changes in brain and spinal tryptophan and 5-hydroxyindoleacetic acid levels following acute morphine administration in normal and arthritic rats. Brain Res. 1979; 175: 291–301
   PubMedGoogle Scholar
• Wu Y., Shaghaghi E. K., Jacquot C., Pallardy M., Gardier A. M. Synergism between interleukin-6 and inter-leukin-1beta in hypothalamic serotonin release: a reverse in vivo microdialysis study in F344 rats. Eur. Cytokine Netw. 1999; 10: 57–64
   PubMedGoogle Scholar
• Young M. R., Kut I. L., Coogan M. P., Wright M. A., Young M. E., Matthews J. Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. Immunology 1993; 80: 395–400
   PubMed Web of Science ®Google Scholar
• Young M. R., Matthews J. P. Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology 1995; 84: 148–152
   PubMedGoogle Scholar